Our most popular links (they might take a few seconds to load - they're worth the wait!):



Cephalon Reports Continued Strong Earnings Growth


Cephalon Reports Continued Strong Earnings Growth

home   >   MSN news

... Sales of PROVIGIL(R)(modafinil) Tablets [C-IV] increased 6 percent to $100.1 million ... result of recent acquisitions. PROVIGIL, ACTIQ, and GABITRIL each experienced double-digit ...

- link to Cephalon Reports Continued Strong Earnings Growth -
Last update: 05/26/2005


Recommended Reading

    Zyprexa PAI forces Lilly's hand on media fill issues.(performance audit inspection on Eli Lilly and Co.) : An article from: Validation Times
    Remicade - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
    Aranesp studies show potential in anemia teatment paradigms.(Brief Article) : An article from: BIOTECH Patent News
    Two more drugs approved for social anxiety. (Sertraline, Venlafaxine). : An article from: Internal Medicine News
    Intensive statin regimen may halt atherosclerosis: measured by intravascular ultrasound: 'maximally intensive ... therapy can completely halt the dise ... News) : An article from: Family Practice News
    Aranesp studies show potential in anemia teatment paradigms.(Brief Article) : An article from: BIOTECH Patent News
    Zoloft, Paxil, Luvox and Prozac: All New Information to Help You Choose the Right Antidepressant
    Fosamax: A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References